Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202502603434615Completed
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by individual. Primary endpoint: Blood pressure control at 8 months. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202502603434615.